EGF Theramed Health Corp. (CSE:TMED)

Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
At close: Nov 19, 2025
-55.00%
Market Cap1.05M
Revenue (ttm)n/a
Net Income (ttm)-3.22M
Shares Out11.62M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,000
Average Volume7,906
Open0.0950
Previous Close0.0900
Day's Range0.0900 - 0.0950
52-Week Range0.0650 - 0.3300
Beta0.61
RSI45.89
Earnings DateFeb 26, 2026

About EGF Theramed Health

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada. [Read more]

Sector Healthcare
CEO Connor Yuen
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.